InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Johnson Anne Nagengast. Director active across 1 company, notably ATAI Life Sciences N.V.. In total, 4 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €89k. Activity tracked since 2 April 2024. The latest transaction was filed on 21 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Johnson Anne Nagengast is a declarant linked to ATAI Life Sciences N.V., where she is Chief Financial Officer. The record covers 4 filings in total, and the most recent filings sampled run from 2024-03-15 to 2025-03-24, with EUR 0 of buys and EUR 88802 of sells in that sample, the most frequent transaction nature being Sale.